PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Jefferies Financial Group Inc.'s Holding History (CIK: 0000096223)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 5,000 Value ($000) $437 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 821,503 Value ($000) $54,572 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 824,019 Value ($000) $45,544 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 631,893 Value ($000) $30,558 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 1,489,495 Value ($000) $57,495 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 1,814,696 Value ($000) $81,661 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 2,040,561 Value ($000) $70,705 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 1,180,561 Value ($000) $34,154 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 1,270,561 Value ($000) $29,134 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 835,561 Value ($000) $13,937 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 760,561 Value ($000) $21,007 Avg Close $25.03 Range $17.64 - $30.10
Q4 2022
Shares 100,000 Value ($000) $1,091 Avg Close $8.44 Range $7.24 - $11.46